Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Why KKR is set to buy Eugin – and Fresenius wants to sell

Global investment company KKR is set to buy Eugin, the Spain-based fertility subsidiary owned by Germany-based conglomerate Fresenius, for €500m. We ask why KKR might want it, and whether it makes sense for Fresenius to sell.

Record fines are putting care homes at risk

With UK for-profit group Cygnet Health Care being fined £1.5m last month following the death of an inpatient at Ealing Hospital in 2019 - the largest ever penalty imposed on a mental health provider - we speak to four European experts to consider how punitive fines from regulators are impacting providers’ bottom line.

KKR set to buy Eugin for €500m

US-based global investment company KKR looks set to buy Eugin, the Spain-based fertility group owned by Germany-based conglomerate Fresenius, with which it is reportedly in exclusive talks. The deal values Eugin at around €500m.

Panic rush to do deals ahead of Lauterbach reforms

HBI hears that a glut of M&A deals are being rushed through, with panicking investors and operators competing for buyers before Federal Health Minister Karl Lauterbach's controversial reforms pass - though it remains unclear exactly what those reforms will be. HBI asks whether the panic is merited, just how low have multiples dropped, and who will benefit from this?

Cinven goes ahead with Synlab take-private

UK PE group Cinven is pushing ahead with its €10-per-share acquisition of multinational labs group Synlab by launching a public acquisition offer to all shareholders. This comes after several months of slience after Cinven made an initial non-binding offer to take the group private back in March. 

Median expands into third major European market

Waterland-owned Germany and UK rehabilitation and mental health specialist Median has expanded into a third major market with the acquisition of Hestia Alliance in Spain. HBI asks "why Spain?"

Why it pays to do the basics when building a patient pathway

A German outpatient operator tells HBI how providers are attracting and keeping patients within their businesses throughout the patient pathway, with as many as 50% of complex ophthalmology referrals coming from internal sources. HBI hears it pays to do basic (less profitable) work and even consider retail early in the patient journey so when they really do need help, they already have a provider of choice.

Alliance Medical sale “imminent”

HBI hears that the longstanding sale of UK diagnostic firm Alliance Medical Group is imminent, with two bidders left in the process and pan-European operator Affidea tipped to be the front-runner. We speak to three market experts to find out more about the deal which is being valued at around $800m-$1bn.

German for profits’ growing influence in the healthcare sector

Germany's for-profit hospital sector has a growing role in the market's provision. Between 2014 and 2021, the percentage of German hospitals which were owned by the for-profit sector rose 2.3 percentage points to 44.5% and the number of beds controlled by the for-profit sector rose 0.9 percentage points to 24%.

Find Us